These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15906589)

  • 1. Effect of exercise on transdermal nicotine release in healthy habitual smokers.
    Bur A; Joukhadar C; Klein N; Herkner ; Mitulovic G; Schmid R; Agneter E; Müller M; Brunner M
    Int J Clin Pharmacol Ther; 2005 May; 43(5):239-43. PubMed ID: 15906589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise.
    Homsy W; Yan K; Houle JM; Besner JG; Gossard D; Pierce CH; Caillé G
    J Clin Pharmacol; 1997 Aug; 37(8):728-36. PubMed ID: 9378845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
    Gupta SK; Hwang SS; Causey D; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 Oct; 35(10):985-9. PubMed ID: 8568016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical exercise increases plasma concentrations of nicotine during treatment with a nicotine patch.
    Klemsdal TO; Gjesdal K; Zahlsen K
    Br J Clin Pharmacol; 1995 Jun; 39(6):677-9. PubMed ID: 7654487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of application sites and multiple doses on nicotine pharmacokinetics in healthy male Japanese smokers following application of the transdermal nicotine patch.
    Sobue S; Sekiguchi K; Kikkawa H; Irie S
    J Clin Pharmacol; 2005 Dec; 45(12):1391-9. PubMed ID: 16291714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
    Gupta SK; Okerholm RA; Coen P; Prather RD; Gorsline J
    J Clin Pharmacol; 1993 Feb; 33(2):169-74. PubMed ID: 8440767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of plasma nicotine concentrations after application of nicoderm (nicotine transdermal system) to different skin sites.
    Gorsline J; Okerholm RA; Rolf CN; Moos CD; Hwang SS
    J Clin Pharmacol; 1992 Jun; 32(6):576-81. PubMed ID: 1634647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol.
    Gupta SK; Okerholm RA; Eller M; Wei G; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 May; 35(5):493-8. PubMed ID: 7657849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man.
    Pellegrini MP; Newby DE; Maxwell S; Webb DJ
    Cardiovasc Res; 2001 Nov; 52(2):321-7. PubMed ID: 11684081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the minimal trauma tissue biopsy to transdermal clinical pharmacokinetic studies.
    Schrolnberger C; Brunner M; Mayer BX; Eichler HG; Müller M
    J Control Release; 2001 Aug; 75(3):297-306. PubMed ID: 11489317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditions.
    Caspary S; Keller-Stanislawski B; Huber T; Merz PG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):92-5. PubMed ID: 2071260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine.
    Vanakoski J; Seppälä T; Sievi E; Lunell E
    Clin Pharmacol Ther; 1996 Sep; 60(3):308-15. PubMed ID: 8841153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches.
    Fant RV; Henningfield JE; Shiffman S; Strahs KR; Reitberg DP
    Pharmacol Biochem Behav; 2000 Nov; 67(3):479-82. PubMed ID: 11164075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nicotine pharmacokinetics in healthy Japanese male smokers following application of the transdermal nicotine patch and cigarette smoking.
    Sobue S; Sekiguchi K; Kikkawa H; Akasaki M; Irie S
    Biol Pharm Bull; 2006 May; 29(5):1068-73. PubMed ID: 16651750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and timing of adverse experiences during trandsdermal nicotine therapy.
    Gourlay SG; Forbes A; Marriner T; McNeil JJ
    Drug Saf; 1999 Jun; 20(6):545-55. PubMed ID: 10392670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) in women and obese men compared with normal-sized men.
    Prather RD; Tu TG; Rolf CN; Gorsline J
    J Clin Pharmacol; 1993 Jul; 33(7):644-9. PubMed ID: 8366189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.
    Ross HD; Chan KK; Piraino AJ; John VA
    Pharm Res; 1991 Mar; 8(3):385-8. PubMed ID: 2052530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute effects of daily nicotine intake on heart rate--a toxicokinetic and toxicodynamic modelling study.
    Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):312-24. PubMed ID: 25066669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.